The Microbe,
Год журнала:
2024,
Номер
4, С. 100143 - 100143
Опубликована: Авг. 15, 2024
The
emergence
of
the
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
as
a
global
threat
has
driven
urgent
need
for
identification
bioactive
molecules
capable
controlling
or
completely
eradicating
this
virus.
Our
group
been
investigating
isatin
hybrids
that
block
binding
human
angiotensin-converting
enzyme
(ACE2)
and
viral
spike
protein.
This
work
describes
synthesis
biological
evaluation
two
derivatives
(indol-2,3-dione)
based
on
computational
approach.
Isatin,
secondary
metabolite
tryptophan,
used
core
structure
is
versatile
favorable
precursor
privileged
scaffold
against
complex.
new
compound
scaffolds
AVS-01
AVS-02
were
designed
by
modifications
at
C-3
N-1
positions,
respectively,
according
to
various
reagents
available
in
our
lab.
Molecular
docking
compounds
was
explore
their
interactions
with
target
protein
shown
article
showed
quite
distinct
glide
scores
(GScore
=
−3.657
−4.534
AVS-02,
respectively).
Several
analogs
synthesized
tested
quest
find
plausible
further
synthesis.
While
inhibition
spike/ACE2
an
IC50
value
8.8
µM,
reference
hopeaphenol
inhibited
interaction
0.3
µM.
Compound
rather
no
SARS-CoV-2
spike/host
ACE2
>
32
An
estimation
free
energy
(ΔGbind),
solvation
(ΔGsolv)
MM-GBSA
calculations
carried
out
re-evaluate
affinity
gain
insights
into
observed
activity
non-activity.
calculation
ΔGbind
−35.91
kcal/mol
and-25.32
ΔGsolv
25.56
16.92
respectively.
leads
conclusion
position
indole-2,3-dione
moiety
favors
blockage
compared
position.
Analysis
GScores,
per-residue
energies,
energies
van
der
Waals
should
favor
towards
Biomedicines,
Год журнала:
2021,
Номер
9(6), С. 689 - 689
Опубликована: Июнь 18, 2021
As
a
public
health
emergency
of
international
concern,
the
highly
contagious
coronavirus
disease
2019
(COVID-19)
pandemic
has
been
identified
as
severe
threat
to
lives
billions
individuals.
Lung
cancer,
malignant
tumor
with
highest
mortality
rate,
brought
significant
challenges
both
human
and
economic
development.
Natural
products
may
play
pivotal
role
in
treating
lung
diseases.
We
reviewed
published
studies
relating
natural
products,
used
alone
or
combination
US
Food
Drug
Administration-approved
drugs,
active
against
acute
respiratory
syndrome
2
(SARS-CoV-2)
cancer
from
1
January
2020
31
May
2021.
A
wide
range
can
be
considered
promising
anti-COVID-19
anti-lung
agents
have
gained
widespread
attention,
including
monotherapy
for
treatment
SARS-CoV-2
(ginkgolic
acid,
shiraiachrome
A,
resveratrol,
baicalein)
(daurisoline,
graveospene
deguelin,
erianin)
FDA-approved
anti-SARS-CoV-2
(cepharanthine
plus
nelfinavir,
linoleic
acid
remdesivir)
(curcumin
cisplatin,
celastrol
gefitinib).
demonstrated
potential
value
assistance
nanotechnology,
drug
therapies,
codrug
strategy,
this
“natural
remedy”
could
serve
starting
point
further
development
these
Chemical Papers,
Год журнала:
2024,
Номер
78(6), С. 3431 - 3441
Опубликована: Март 14, 2024
Abstract
Chemical
prototypes
with
broad-spectrum
antiviral
activity
are
important
toward
developing
new
therapies
that
can
act
on
both
existing
and
emerging
viruses.
Binding
of
the
SARS-CoV-2
spike
protein
to
host
angiotensin-converting
enzyme
2
(ACE2)
receptor
is
required
for
cellular
entry
SARS-CoV-2.
Toward
identifying
chemical
leads
disrupt
this
interaction,
including
in
presence
adaptive
mutations
found
variants
like
omicron
circumvent
vaccine,
immune,
therapeutic
antibody
responses,
we
synthesized
5-chloro-3-(2-(2,4-dinitrophenyl)hydrazono)indolin-2-one
(H
L)
from
condensation
reaction
5-chloroisatin
2,4-dinitrophenylhydrazine
good
yield.
H
L
was
characterised
by
elemental
spectral
(IR,
electronic,
Mass)
analyses.
The
NMR
spectrum
indicated
a
keto–enol
tautomerism,
keto
form
being
more
abundant
solution.
selectively
interfere
binding
receptor-binding
domain
(RBD)
50%
inhibitory
concentration
(IC
50
)
0.26
μM,
compared
an
unrelated
PD-1/PD-L1
ligand–receptor-binding
pair
IC
2.06
μM
vitro
(Selectivity
index
=
7.9).
Molecular
docking
studies
revealed
ligand
preferentially
binds
within
ACE2
site
region
distinct
where
occur.
Consistent
these
models,
able
interactions
RBDs
beta,
delta,
lambda,
similar
activities.
These
indicate
L-derived
compounds
potential
inhibitors
multiple
variants,
those
capable
circumventing
vaccine
immune
responses.
Medicinal Chemistry Research,
Год журнала:
2024,
Номер
33(4), С. 620 - 634
Опубликована: Март 5, 2024
Abstract
Isatin
(indol-2,3-dione),
a
secondary
metabolite
of
tryptophan,
has
been
used
as
the
core
structure
to
design
several
compounds
that
have
tested
and
identified
potent
inhibitors
apoptosis,
potential
antitumor
agents,
anticonvulsants,
antiviral
agents.
In
this
work,
analogs
isatin
hybrids
synthesized
characterized,
their
activities
were
established
both
Aurora
A
kinase
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
spike/host
angiotensin-converting
enzyme
II
(ACE2)
interactions.
Amongst
hybrids,
6a
,
6f
6g
6m
exhibited
inhibitory
(with
IC
50
values
<
5
$$\mu$$
μ
M),
with
GScore
−7.9,
−7.6,
−8.2
−7.7
kcal/mol,
respectively.
Compounds
6i
showed
in
blocking
SARS-CoV-2
spike/ACE2
binding
range
30
−6.4
−6.6
capable
inhibiting
kinase.
Pharmacophore
profiling
indicated
compound
tightly
fits
pharmacophores,
while
6d
6l
pharmacophore.
This
work
is
proof
concept
some
existing
cancer
drugs
may
possess
properties.
Molecular
modeling
active
for
each
protein
adopted
different
modes,
hence
interacting
set
amino
acid
residues
site.
The
weaker
against
could
be
explained
by
small
sizes
ligands
fail
address
important
interactions
ACE2
receptor
The Microbe,
Год журнала:
2024,
Номер
3, С. 100059 - 100059
Опубликована: Март 23, 2024
In
silico
binding
studies
were
conducted
on
the
known
plant-derived
polyphenolic
tetrameric
stilbenoids,
(–)-hopeaphenol
(1),
vaticanol
B
(2)
and
vatalbinoside
A
(3)
their
monomeric
derivative
resveratrol
(8),
identified
from
several
plant
species.
The
natural
products
1–3
had
been
previously
evaluated
against
SARS-CoV-2
protein
targets
responsible
for
viral
transmission
infection.
two
isomeric
compounds
displayed
a
high
affinity
blocking
of
spike
with
human
angiotensin-converting
enzyme
2
(ACE2).
Molecular
docking
molecular
dynamics
simulations
have
used
to
attempt
explain
spike/ACE2
complex.
hydrophobic
properties
respective
target
sites
computed
compared
physicochemical
each
compound
toward
site.
ADMET/DMPK
profiles
also
demonstrate
potential
fragments
as
lead
antiviral
discovery.
These
results
reported
here
support
experimental
data
obtained
date
clearly
identify
stilbenoid
structure
class
one
worthy
future
during
chemical
biology
and/or
drug
discovery
efforts.
Molecules,
Год журнала:
2024,
Номер
29(14), С. 3427 - 3427
Опубликована: Июль 22, 2024
Phenolic
compounds
are
the
main
special
metabolites
of
Cyperaceae
species
from
phytochemical,
pharmacological,
and
chemotaxonomical
points
view.
The
present
study
focused
on
isolation,
structure
determination,
pharmacological
investigation
constituents
Carex
praecox.
Twenty-six
compounds,
including
lignans,
stilbenes,
flavonoids,
megastigmanes,
chromenes,
phenylpropanoids,
were
identified
methanol
extract
plant.
Five
these
namely,
carexines
A–E,
previously
undescribed
natural
products.
All
isolated
for
first
time
C.
ACE-inhibitory
activity
seven
stilbenoid
was
tested,
(–)-hopeaphenol
proved
to
be
most
active
(IC50
7.7
±
0.9
μM).
enzyme–kinetic
studies
revealed
a
mixed-type
inhibition;
therefore,
domain-specific
also
conducted.
in
silico
docking
ACE
affirmed
some
favorable
interactions.
In
addition,
antiproliferative
antibacterial
effects
evaluated.
Nutrients,
Год журнала:
2022,
Номер
14(7), С. 1390 - 1390
Опубликована: Март 26, 2022
Patients
affected
by
coronavirus
disease
2019
(COVID-19)
demonstrate
a
range
of
hemostasis
dysfunctions,
such
as
coagulation
dysfunction
and
changes
in
blood
platelet
function,
this
being
major
cause
death.
These
complications
may
also
be
associated
with
oxidative
stress.
Recently,
various
papers,
including
some
reviews,
have
suggested
that
the
use
dietary
bioactive
compounds,
phenolic
play
significant
role
treatment
COVID-19.
However,
while
curcumin,
resveratrol,
myricetin
scutellarian,
been
found
to
antiviral
effects
against
COVID-19,
recommendations
regarding
compounds
prevent
or
reduce
risk
CVDs
during
COVID-19
infection
remain
tentative.
The
present
mini-review
examines
antioxidant,
anti-platelet
anticoagulant
activities
selected
possible
implications
for
their
treating
This
review
whether
these
can
promising
agents
modulation
While
properties
well
documented
vitro
vivo
studies,
particularly
positive
prophylaxis
CVDs,
less
is
known
prophylactic
potential
no
credible
evidence
exists
efficiency
humans
animals.
In
cases,
studies
are
available.
Therefore,
it
cannot
unequivocally
stated
offers
benefits
patients
Nutrients,
Год журнала:
2022,
Номер
14(11), С. 2194 - 2194
Опубликована: Май 25, 2022
Coronavirus
illness
(COVID-19)
is
an
infectious
pathology
generated
by
intense
severe
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
This
disease
has
emerged
in
2019.
The
COVID-19-associated
pandemic
considerably
affected
the
way
of
life
and
economy
world.
It
consequently
crucial
to
find
solutions
allowing
remedying
or
alleviating
effects
this
disease.
Natural
products
have
been
perpetual
application
from
immemorial
time
given
that
they
are
attested
be
efficient
towards
several
illnesses
without
major
side
effects.
Various
studies
shown
plant
extracts
purified
molecules
a
promising
inhibiting
impact
coronavirus.
In
addition,
it
substantial
understand
characteristics,
susceptibility
diet
on
patients
infected
with
COVID-19.
review,
we
recapitulate
influence
pure
medicinal
plants
We
approach
possibilities
treatment/co-treatment
feeding
applied
also
show
complications
associated
nutrient
deficiencies
then
discuss
food
groups
COVID-19
pathogenesis.
Then,
covered
emerging
technologies
using
plant-based
SARS-CoV-2
vaccine.
conclude
giving
curative
therapy
recommendations
which
potential
interest
infection
could
pave
for
pharmacological
treatments
co-treatments